Notably, GSH acts as a critical antioxidant that protects cancer cells from any form of programmed cell death (i.e., autophagy, apoptosis, necroptosis, and ferroptosis) 50,51,52
Findings showed that semaglutide was linked to a significantly lower AD risk, with the most pronounced risk reduction observed in comparison to insulin (hazard ratio [HR] 0.33, 95% CI: 0.210.51), and a somewhat lower, though still substantial, reduction when compared to other glucagon-like peptide-1 receptor agonists (GLP-1RAs
Micic D, Popovic V, Kendereski A, Macut D, Casanueva FF, Dieguez C
[DOI] [PubMed] [Google Scholar] 84.McMorrow HE, Lorch CM, Hayes NW, Fleps SW, Frydman JA, Xia JL, et al
The mechanism of action involves binding to GLP-1 receptors found predominantly in pancreatic beta cells, where they enhance glucose-dependent insulin secretion
And what does Knudsen think about all this